- Active not recruitingPHASE3
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
This study is looking into a new treatment called Trontinemab for people in the early stages of Alzheimer's disease. Researchers want to see if it's safe and helps improve or slow down symptoms compared to a dummy treatment (placebo).
For: Alzheimers DiseaseUnited States · Argentina · Brazil - Active not recruitingPHASE3
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
This study is testing a new medication called Trontinemab for people in the early stages of Alzheimer's disease. Researchers want to see if it's safe and effective in slowing down memory and thinking problems. They will compare it to a dummy drug (placebo).
For: Alzheimers DiseaseUnited States · Argentina · Australia - RecruitingPHASE3
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
This study is looking into a new medication called Trontinemab for people who are at risk of developing Alzheimer's disease but don't yet have symptoms. We want to see if it's safe and if it can help slow down or stop the disease from progressing.
For: Alzheimer's DiseaseUnited States · Canada · China